| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $124.5M | +138.6% |
| Cost of Revenue | $17.8M | +332.2% |
| R&D Expense | $35.5M | +1.0% |
| SG&A Expense | $134.4M | +75.5% |
| Operating Income | -$63.3M | +0.8% |
| Interest Expense | $5.0M | +45.6% |
| Pre-tax Income | -$65.5M | +2.5% |
| Income Tax | $547K | +6737.5% |
| Net Income | -$66.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.5M | -77.7% |
| Accounts Receivable | $22.0M | +184.9% |
| Inventory | $49.5M | +74.6% |
| Current Assets | $246.1M | +60.2% |
| Total Assets | $297.6M | +56.6% |
| Current Liabilities | $50.4M | -23.2% |
| Long-term Debt | $49.8M | +86.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.7M | -28.1% |
| Capital Expenditures | $344K | +525.5% |
| Investing Cash Flow | -$131.2M | -812.7% |
| Financing Cash Flow | $146.3M | +94.2% |
| Free Cash Flow | -$90.1M | -28.5% |
| +1.7% |
| EPS (Basic) | -$0.30 | +28.6% |
| EPS (Diluted) | -$0.30 | +28.6% |
| Total Liabilities |
| $130.8M |
| +42.5% |
| Stockholders' Equity | $166.8M | +69.7% |